10 employees
Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune.
2021
$47M
from 4 investors over 4 rounds
Nuvig Therapeutics Inc. raised $47M on May 11, 2022
Investors: Digitalis Ventures, Novo Holdings, Bristol-Myers Squibb, UK and Mission BioCapital